Equity Based Compensation (Details) (USD $)	3 Months Ended	35 Months Ended	3 Months Ended		12 Months Ended	3 Months Ended			35 Months Ended	3 Months Ended
	Jun. 30, 2013	Jun. 30, 2013	Jun. 30, 2013 Stock Options	Jun. 30, 2012 Stock Options	Mar. 31, 2013 Stock Options	Jun. 30, 2013 Stock Options Minimum	Jun. 30, 2013 Stock Options Maximum	Jun. 30, 2013 Warrants Issued for Services	Jun. 30, 2013 Warrants Issued for Services	Jun. 30, 2013 Warrants Issued for Services Minimum	Jun. 30, 2013 Warrants Issued for Services Maximum	Jun. 30, 2013 Employee Plan Stock Options	Aug. 27, 2012 Employee Plan Stock Options	Jun. 30, 2013 Director Plan Stock Options	Aug. 27, 2012 Director Plan Stock Options	Aug. 30, 2013 Director Plan Stock Options Subsequent Event
Equity Based Compensation
Shares authorized for issuance before amendment													13,500,000
Shares authorized for issuance															8,200,000	96,700,000
Increase in shares authorized expressed as a percentage of outstanding capital stock														10.00%
Shares remained available for issuance												9,470,000		3,725,000
Fair value assumptions
Expected Term						1 month 10 days	9 years 9 months 4 days			7 months 6 days	4 years 10 months 24 days
Volatility, Minimum (as a percent)			113.40%					141.20%
Volatility, Maximum (as a percent)			181.50%					162.30%
Risk-Free Rate, minimum (as a percent)			0.04%					0.11%
Risk-Free Rate, maximum (as a percent)			2.00%					1.38%
Shares
Outstanding at the beginning of the period (in shares)			9,608,000
Granted (in shares)			100,000
Forfeited or expired (in shares)			1,203,000
Outstanding at the end of the period (in shares)			8,505,000		9,608,000
Vested at the end of the period (in shares)			6,573,000
Weighted-Average Exercise Price
Outstanding at the beginning of the period (in dollars per share)			$ 3.20
Granted (in dollars per share)			$ 0.30
Forfeited or expired (in dollars per share)			$ 3.01
Outstanding at the end of the period (in dollars per share)			$ 3.19		$ 3.20
Vested at the end of the period (in dollars per share)			$ 3.70
Weighted-Average Remaining Term
Outstanding at the beginning of the period			8 years 10 months 24 days		9 years 2 months 12 days
Granted during the period			1 month 10 days
Outstanding at the end of the period			8 years 10 months 24 days		9 years 2 months 12 days
Vested the end of the period			8 years 8 months 12 days
Additional disclosures
Weighted average grant date fair value (in dollars per share)			$ 0.30
Non-vested Stock Options, Shares
Non-vested at the beginning of the period (in shares)			2,994,000
Granted (in shares)			100,000
Vested (in shares)			(162,000)
Forfeited (in shares)			(1,000,000)
Non-vested at the end of the period (in shares)			1,932,000		2,994,000
Non-vested Stock Options, Weighted Average Grant Date Fair Value
Non-vested at the beginning of the period (in dollars per share)			$ 2.06
Granted (in dollars per share)			$ 0.01
Vested (in dollars per share)			$ 0.24
Forfeited (in dollars per share)			$ 2.57
Non-vested at the end of the period (in dollars per share)			$ 1.76		$ 2.06
Additional disclosures
Total unrecognized compensation expense (in dollars)			$ 700,000
Weighted-average period over which cost is expected to be recognized							1 year
Stock-based compensation costs			1,000,000	400,000				3,300,000
Stock compensation capitalized (in dollars)	$ 361,000	$ 3,439,000	$ 400,000					$ 400,000	$ 400,000
Number of common stock that can be purchased against warrants (in shares)								4,926,808	4,926,808
Exercise price (in dollars per share)										$ 0.22	$ 5.02
Warrants committed for issuance in the next twelve months (in shares)								50,000	50,000